{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:05:53Z","timestamp":1793145953905,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-026-00575-9","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:52:50Z","timestamp":1781772770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Large-scale transcriptomic data mining using explainable XGBoost and SHAP reveals shared biomarkers and molecular mechanisms between type-2 diabetes and triple-negative breast cancer for drug repurposing"],"prefix":"10.1186","volume":"19","author":[{"given":"Md. Feroj","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasfia","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abdul","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Foysal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Bashak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewan Mumdood","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sanoar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Nurul Haque","family":"Mollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"2","key":"575_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247\u201369. https:\/\/doi.org\/10.1007\/s00404-015-3859-y.","journal-title":"Arch Gynecol Obstet"},{"issue":"19","key":"575_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cancers13194992","volume":"13","author":"F Zhang","year":"2021","unstructured":"Zhang F, de Haan-Du J, Sidorenkov G, Landman GWD, Jalving M, Zhang Q, et al. Type 2 diabetes mellitus and clinicopathological tumor characteristics in women diagnosed with breast cancer: a systematic review and meta-analysis. Cancers (Basel). 2021;13(19):13. https:\/\/doi.org\/10.3390\/cancers13194992.","journal-title":"Cancers (Basel)"},{"key":"575_CR3","doi-asserted-by":"publisher","unstructured":"Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. 2012;23:vi7\u201312. https:\/\/doi.org\/10.1093\/annonc\/mds187.","DOI":"10.1093\/annonc\/mds187"},{"issue":"20","key":"575_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"D Foulkes","year":"2010","unstructured":"Foulkes D, Smith E, Reis-Filho S. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348. https:\/\/doi.org\/10.1056\/NEJMra1001389.","journal-title":"N Engl J Med"},{"issue":"1","key":"575_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. Npj Breast Cancer. 2022;8(1):8. https:\/\/doi.org\/10.1038\/s41523-022-00468-0.","journal-title":"Npj Breast Cancer"},{"issue":"2","key":"575_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","volume":"161","author":"X Li","year":"2017","unstructured":"Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, et al. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat. 2017;161(2):279\u201387. https:\/\/doi.org\/10.1007\/s10549-016-4059-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"575_CR7","first-page":"2003","volume":"73","author":"H Kaneto","year":"2015","unstructured":"Kaneto H. [Pathophysiology of type 2 diabetes mellitus]. Nihon Rinsho. 2015;73(12):2003\u201307.","journal-title":"Nihon Rinsho"},{"issue":"5","key":"575_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/18756417MTAxgODQqy","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A. Type 2 diabetes and its impact on the immune System. CDR. 2020;16(5):442\u201349. https:\/\/doi.org\/10.2174\/18756417MTAxgODQqy.","journal-title":"CDR"},{"issue":"19","key":"575_CR9","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/diagnostics14192132","volume":"14","author":"A Asiri","year":"2024","unstructured":"Asiri A, Al Qarni A, Bakillah A. The interlinking metabolic association between type 2 diabetes mellitus and cancer: molecular mechanisms and therapeutic insights. Diagnostics. 2024;14(19):2132. https:\/\/doi.org\/10.3390\/diagnostics14192132.","journal-title":"Diagnostics"},{"issue":"14","key":"575_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/diagnostics13142390","volume":"13","author":"S Matou-Nasri","year":"2023","unstructured":"Matou-Nasri S, Aldawood M, Alanazi F, Khan AL. Updates on triple-negative breast cancer in type 2 diabetes mellitus patients: from risk factors to diagnosis, biomarkers and therapy. Diagnostics. 2023;13(14):13. https:\/\/doi.org\/10.3390\/diagnostics13142390.","journal-title":"Diagnostics"},{"issue":"3","key":"575_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.annonc.2020.12.008","volume":"32","author":"YMM Park","year":"2021","unstructured":"Park YMM, Bookwalter DB, O\u2019Brien KM, Jackson CL, Weinberg CR, Sandler DP. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer. Ann Oncol. 2021;32(3):351\u201359. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.008.","journal-title":"Ann Oncol"},{"issue":"11","key":"575_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9112358","volume":"9","author":"O Treeck","year":"2020","unstructured":"Treeck O, Sch\u00fcler-Toprak S, Ortmann O. Estrogen actions in triple-negative breast cancer. Cells. 2020;9(11):1\u201315. https:\/\/doi.org\/10.3390\/cells9112358.","journal-title":"Cells"},{"key":"575_CR13","doi-asserted-by":"publisher","unstructured":"Hossain FM, Danos DM, Fu Q, Wang X, Scribner RA, Chu ST, et al. Association of Obesity and diabetes with the incidence of breast cancer in Louisiana. Am J Prev Med. 2022;63(1):S83\u201392. https:\/\/doi.org\/10.1016\/j.amepre.2022.02.017.","DOI":"10.1016\/j.amepre.2022.02.017"},{"issue":"11","key":"575_CR14","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/1055-9965.EPI-19-0291","volume":"28","author":"H Chen","year":"2019","unstructured":"Chen H, Cook LS, Tang MTC, Hill DA, Wiggins CL, Li CI. Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer. Cancer Epidem Biomar. 2019;28(11):1802\u201308. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0291.","journal-title":"Cancer Epidem Biomar"},{"issue":"5","key":"575_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23052705","volume":"23","author":"M Cejuela","year":"2022","unstructured":"Cejuela M, Martin-Castillo B, Menendez JA, Pernas S. RETRACTED: metformin and breast cancer: where are we Now? IJMS. 2022;23(5):23. https:\/\/doi.org\/10.3390\/ijms23052705.","journal-title":"IJMS"},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/183928","volume":"2015","author":"P Ferroni","year":"2015","unstructured":"Ferroni P, Riondino S, Buonomo O, Palmirotta R, Guadagni F, Roselli M. Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress. Oxidative Med Cellular Longevity. 2015;2015:1\u201310. https:\/\/doi.org\/10.1155\/2015\/183928.","journal-title":"Oxidative Med Cellular Longevity"},{"key":"575_CR17","doi-asserted-by":"crossref","unstructured":"Mitra S, Acharyya S. Identification of disease critical genes for triple negative breast cancer, TNBC, using particle swarm optimization, PSO, with machine learning. 2023 5th int. Conf Electr Comput Commun Technol ICECCT. 2023.","DOI":"10.1109\/ICECCT56650.2023.10179746"},{"key":"575_CR18","doi-asserted-by":"crossref","unstructured":"Lai S, Wang S, Ma R, et al. Exploration of prognostic value and underlying mechanism of P2RY14 in triple negative breast cancer by multi-omics. 2023.","DOI":"10.21203\/rs.3.rs-2795229\/v1"},{"key":"575_CR19","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2147\/CMAR.S295951","volume":"13","author":"L Li","year":"2021","unstructured":"Li L, Huang H, Zhu M, Wu J. Identification of hub genes and pathways of triple negative breast cancer by expression profiles analysis. CMAR. 2021;13:2095\u2013104. https:\/\/doi.org\/10.2147\/CMAR.S295951.","journal-title":"CMAR"},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.2147\/OTT.S166567","volume":"11","author":"MX Li","year":"2018","unstructured":"Li MX, Jin LT, Wang TJ, Feng Y-J, Pan C-P, Zhao D-M, et al. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis. OTT. 2018;11:4105\u201312. https:\/\/doi.org\/10.2147\/OTT.S166567.","journal-title":"OTT"},{"issue":"2","key":"575_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4093\/dmj.2019.0204","volume":"45","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yao S, Ding JM, Chen W, Guo Y. Enhancer-gene interaction analyses identified the epidermal growth factor receptor as a susceptibility gene for type 2 diabetes mellitus. Diabetes Metab J. 2021;45(2):241\u201350. https:\/\/doi.org\/10.4093\/dmj.2019.0204.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"575_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41598-024-69302-w","volume":"14","author":"R Ahmmed","year":"2024","unstructured":"Ahmmed R, Hossen MB, Ajadee A, Mahmud S, Ali MA, Mollah MMH, et al. Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications. Sci Rep. 2024;14(1):14. https:\/\/doi.org\/10.1038\/s41598-024-69302-w.","journal-title":"Sci Rep"},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmolb.2024.1410004","volume":"11","author":"G Xu","year":"2024","unstructured":"Xu G, Zhao Y, Bai Y, Lin Y. Study of hub nodes of transcription factor-target gene regulatory network and immune mechanism for type 2 diabetes based on chip analysis of GEO database. Front Mol Biosci. 2024;11:11. https:\/\/doi.org\/10.3389\/fmolb.2024.1410004.","journal-title":"Front Mol Biosci"},{"key":"575_CR24","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical Power analysis for the behavioral sciences. Stat. Power Anal Behav Sci. 2013;1\u2013567.","DOI":"10.4324\/9780203771587"},{"issue":"6","key":"575_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1261\/rna.053959.115","volume":"22","author":"NJ Schurch","year":"2016","unstructured":"Schurch NJ, Schofield P, Gierli\u0144ski M, Cole C, Sherstnev A, Singh V, et al. How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? RNA. 2016;22(6):839\u201351. https:\/\/doi.org\/10.1261\/rna.053959.115.","journal-title":"RNA"},{"issue":"1","key":"575_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12859-023-05578-5","volume":"24","author":"A Behdenna","year":"2023","unstructured":"Behdenna A, Colange M, Haziza J, Gema A, App\u00e9 G, Azencott C-A, et al. pyCombat, a Python tool for batch effects correction in high-throughput molecular data using empirical Bayes methods. BMC Bioinf. 2023;24(1):24. https:\/\/doi.org\/10.1186\/s12859-023-05578-5.","journal-title":"BMC Bioinf"},{"key":"575_CR27","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"key":"575_CR28","doi-asserted-by":"publisher","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","DOI":"10.1093\/nar\/gkac1000"},{"issue":"11","key":"575_CR29","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"issue":"S4","key":"575_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(S4):8. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"key":"575_CR31","unstructured":"Chen T, He T, Benesty M. XGBoost: eXtreme Gradient Boosting. R Packag. Version 0.71-2. 2024;1\u20134."},{"issue":"1","key":"575_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12031-025-02309-8","volume":"75","author":"J Jia","year":"2025","unstructured":"Jia J, Niu L, Feng P, Liu S, Han H, Zhang B, et al. Identification of novel biomarkers for ischemic stroke through integrated Bioinformatics analysis and machine learning. J Mol Neurosci. 2025;75(1):75. https:\/\/doi.org\/10.1007\/s12031-025-02309-8.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"575_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12967-022-03369-9","volume":"20","author":"Q Li","year":"2022","unstructured":"Li Q, Yang H, Wang P, Liu X, Lv K, Ye M. Xgboost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J Transl Med. 2022;20(1):20. https:\/\/doi.org\/10.1186\/s12967-022-03369-9.","journal-title":"J Transl Med"},{"key":"575_CR34","doi-asserted-by":"publisher","first-page":"49693","DOI":"10.1109\/ACCESS.2025.3552280","volume":"13","author":"SE Aliouane","year":"2025","unstructured":"Aliouane SE, Chehili H, Boulahrouf K, Abdelaziz A, Khlifa N, Hamidechi MA. Integrating deep learning and SHAP for breast cancer classification and biomarker Discovery using gene expression data. IEEE Access. 2025;13:49693\u2013709. https:\/\/doi.org\/10.1109\/ACCESS.2025.3552280.","journal-title":"IEEE Access"},{"issue":"4","key":"575_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrg2538","volume":"10","author":"JM Vaquerizas","year":"2009","unstructured":"Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nat Rev Genet. 2009;10(4):252\u201363. https:\/\/doi.org\/10.1038\/nrg2538.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"575_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522\u201331. https:\/\/doi.org\/10.1038\/nrg1379.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"575_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball A, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat Genet"},{"key":"575_CR38","doi-asserted-by":"publisher","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361. https:\/\/doi.org\/10.1093\/nar\/gkw1092.","DOI":"10.1093\/nar\/gkw1092"},{"key":"575_CR39","doi-asserted-by":"publisher","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon J, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024, Jan, 5;52(D1):D174\u201382. https:\/\/doi.org\/10.1093\/nar\/gkad1059.","DOI":"10.1093\/nar\/gkad1059"},{"issue":"2","key":"575_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1261\/rna.2239606","volume":"12","author":"P Sethupathy","year":"2006","unstructured":"Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: a comprehensive database of experimentally supported animal microRNA targets. Rna. 2006;12(2):192\u201397. https:\/\/doi.org\/10.1261\/rna.2239606.","journal-title":"Rna"},{"key":"575_CR41","doi-asserted-by":"publisher","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234\u201341. https:\/\/doi.org\/10.1093\/nar\/gkz240.","DOI":"10.1093\/nar\/gkz240"},{"issue":"1","key":"575_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinf. 2013;14(1):14. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinf"},{"key":"575_CR43","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Moreno A, L\u00f3pez-Dom\u00ednguez R, Ramirez-Mena A, et al. GeneCodis, 4: expanding the modular enrichment analysis to regulatory elements. bioRxiv 2021. 2021.04.15.439962.","DOI":"10.1101\/2021.04.15.439962"},{"key":"575_CR44","doi-asserted-by":"publisher","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u201375. https:\/\/doi.org\/10.1093\/nar\/gkad976.","DOI":"10.1093\/nar\/gkad976"},{"key":"575_CR45","doi-asserted-by":"publisher","unstructured":"Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, et al. Integration of the drug\u2013gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021;49(D1):D1144\u201351. https:\/\/doi.org\/10.1093\/nar\/gkaa1084.","DOI":"10.1093\/nar\/gkaa1084"},{"key":"575_CR46","unstructured":"K S, C J, C T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2018."},{"issue":"15","key":"575_CR47","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","volume":"28","author":"A Volkamer","year":"2012","unstructured":"Volkamer A, Kuhn D, Rippmann F, Rarey M. Dogsitescorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics. 2012;28(15):2074\u201375. https:\/\/doi.org\/10.1093\/bioinformatics\/bts310.","journal-title":"Bioinformatics"},{"key":"575_CR48","first-page":"627","volume":"2017","author":"SK Burley","year":"1607","unstructured":"Burley SK, Berman HM, Kleywegt GJ, et al. Protein data Bank (PDB): the single global macromolecular structure archive. Methods Mol Biol. 1607;2017:627\u201341.","journal-title":"Methods Mol Biol"},{"issue":"13","key":"575_CR49","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede T, et al. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003;31(13):3381\u201385. https:\/\/doi.org\/10.1093\/nar\/gkg520.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"575_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4(1):1\u201317. https:\/\/doi.org\/10.1186\/1758-2946-4-17.","journal-title":"J Cheminform"},{"issue":"16","key":"575_CR51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391. https:\/\/doi.org\/10.1002\/jcc.21256.","journal-title":"J Comput Chem"},{"key":"575_CR52","unstructured":"Discovery Studio visualizer 4.5. 2015."},{"issue":"2","key":"575_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"issue":"3","key":"575_CR54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H van de Waterbeemd","year":"2003","unstructured":"van de Waterbeemd H, Gifford E, van de Waterbeemd H. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2(3):192\u2013204. https:\/\/doi.org\/10.1038\/nrd1032.","journal-title":"Nat Rev Drug Discov"},{"key":"575_CR55","doi-asserted-by":"publisher","unstructured":"Myung Y, De S\u00e1 AGC, Ascher DB. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res. 2024;52(W1):W469\u201375. https:\/\/doi.org\/10.1093\/nar\/gkae254.","DOI":"10.1093\/nar\/gkae254"},{"issue":"9","key":"575_CR56","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","journal-title":"J Med Chem"},{"key":"575_CR57","doi-asserted-by":"publisher","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, et al. Admetlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52(W1):W422\u201331. https:\/\/doi.org\/10.1093\/nar\/gkae236.","DOI":"10.1093\/nar\/gkae236"},{"key":"575_CR58","doi-asserted-by":"publisher","unstructured":"Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439\u201344. https:\/\/doi.org\/10.1093\/nar\/gkab1061.","DOI":"10.1093\/nar\/gkab1061"},{"issue":"9","key":"575_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002;9(9):646\u201352. https:\/\/doi.org\/10.1038\/nsb0902-646.","journal-title":"Nat Struct Biol"},{"issue":"6","key":"575_CR60","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99(6):1129\u201343. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011.","journal-title":"Neuron"},{"issue":"20","key":"575_CR61","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/acs.jcim.3c01136","volume":"63","author":"K Ozvoldik","year":"2023","unstructured":"Ozvoldik K, Stockner T, Krieger E. YASARA model\u2013Interactive molecular modeling from two dimensions to virtual realities. J Chem Inf Model. 2023;63(20):6177\u201382. https:\/\/doi.org\/10.1021\/acs.jcim.3c01136.","journal-title":"J Chem Inf Model"},{"issue":"3","key":"575_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/prot.10104","volume":"47","author":"E Krieger","year":"2002","unstructured":"Krieger E, Koraimann G, Vriend G. Increasing the precision of comparative models with YASARA NOVA\u2014a self-parameterizing force field. Proteins Struct. Funct. Genet. 2002;47(3):393\u2013402. https:\/\/doi.org\/10.1002\/prot.10104.","journal-title":"Proteins Struct. Funct. Genet"},{"key":"575_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmgm.2018.04.014","volume":"83","author":"S Mitra","year":"2018","unstructured":"Mitra S, Dash R. Structural dynamics and quantum Mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors. J Mol Graph Model. 2018;83:42\u201352. https:\/\/doi.org\/10.1016\/j.jmgm.2018.04.014.","journal-title":"J Mol Graph Model"},{"key":"575_CR64","doi-asserted-by":"publisher","unstructured":"Ahmed MF, Al Noman M, Ahmed MF, Latif MA, Pappu MAA, Islam MS, et al. In-silico discovery of pediatric acute-Myeloid-leukemia (pAML) causing druggable molecular signatures highlighting their pathogenetic processes and therapeutic agents through single-cell RNA-Seq profile analysis. PLoS One. 2025;20(10):e0335410. https:\/\/doi.org\/10.1371\/journal.pone.0335410.","DOI":"10.1371\/journal.pone.0335410"},{"issue":"8","key":"575_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18081652","volume":"18","author":"A Casamassimi","year":"2017","unstructured":"Casamassimi A, Federico A, Rienzo M, Esposito S, Ciccodicola A. Transcriptome profiling in human diseases: new advances and perspectives. IJMS. 2017;18(8):18. https:\/\/doi.org\/10.3390\/ijms18081652.","journal-title":"IJMS"},{"key":"575_CR66","doi-asserted-by":"publisher","first-page":"101410","DOI":"10.1016\/j.imu.2023.101410","volume":"43","author":"TA Taz","year":"2023","unstructured":"Taz TA, Arslanturk S. Unveiling genetic variant-level biomarkers for aggressive prostate cancer. Inf Med Unlocked. 2023;43:101410. https:\/\/doi.org\/10.1016\/j.imu.2023.101410.","journal-title":"Inf Med Unlocked"},{"issue":"9","key":"575_CR67","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MAD, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13(9):1042\u201349. https:\/\/doi.org\/10.1038\/nm1638.","journal-title":"Nat Med"},{"issue":"12","key":"575_CR68","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.2337\/db13-0518","volume":"62","author":"L Wang","year":"2013","unstructured":"Wang L, Teng R, Di L, Rogers H, Wu H, Kopp JB, et al. PPAR\u03b1 and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes. 2013;62(12):4122\u201331. https:\/\/doi.org\/10.2337\/db13-0518.","journal-title":"Diabetes"},{"issue":"7","key":"575_CR69","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel Proinflammatory Axis. Cell. 1999;97(7):889\u2013901. https:\/\/doi.org\/10.1016\/S0092-8674(00)80801-6.","journal-title":"Cell"},{"issue":"1","key":"575_CR70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20190297","volume":"217","author":"J Zhao","year":"2020","unstructured":"Zhao J, Chen X, Herjan T, Li X. The role of interleukin-17 in tumor development and progression. J Exp Med. 2020;217(1):217. https:\/\/doi.org\/10.1084\/jem.20190297.","journal-title":"J Exp Med"},{"key":"575_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.biopha.2018.02.103","volume":"101","author":"A Abdel-Moneim","year":"2018","unstructured":"Abdel-Moneim A, Bakery HH, Allam G. The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomed Pharmacother. 2018;101:287\u201392. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.103.","journal-title":"Biomed Pharmacother"},{"key":"575_CR72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2023.1094823","volume":"14","author":"T Shibabaw","year":"2023","unstructured":"Shibabaw T, Teferi B, Ayelign B. The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. Front Immunol. 2023;14:14. https:\/\/doi.org\/10.3389\/fimmu.2023.1094823.","journal-title":"Front. Immunol"},{"issue":"1","key":"575_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbcan.2012.10.003","volume":"1835","author":"J Markowitz","year":"2013","unstructured":"Markowitz J, Carson WE. Review of S100A9 biology and its role in cancer. Biochim et Biophys Acta (BBA) - Rev Cancer. 2013;1835(1):100\u201309. https:\/\/doi.org\/10.1016\/j.bbcan.2012.10.003.","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"issue":"5","key":"575_CR74","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","volume":"184","author":"D He","year":"2010","unstructured":"He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD, et al. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and Myeloid-derived suppressor cells. J Immunol. 2010;184(5):2281\u201388. https:\/\/doi.org\/10.4049\/jimmunol.0902574.","journal-title":"J Immunol"},{"issue":"1","key":"575_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13046-022-02396-0","volume":"41","author":"DC Rigiracciolo","year":"2022","unstructured":"Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Adame-Garcia SR, et al. Focal adhesion kinase (FAK)-Hippo\/YAP transduction signaling mediates the stimulatory effects exerted by S100A8\/A9-RAGE system in triple-negative breast cancer (TNBC). J Exp Clin Cancer Res. 2022;41(1):193. https:\/\/doi.org\/10.1186\/s13046-022-02396-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"575_CR76","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","volume":"1793","author":"E Leclerc","year":"2009","unstructured":"Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2009, (1793): 1793(6):993\u20131007. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.11.016.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"8","key":"575_CR77","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/bjc.2015.346","volume":"113","author":"C Bergenfelz","year":"2015","unstructured":"Bergenfelz C, Gaber A, Allaoui R, Mehmeti M, Jirstr\u00f6m K, Leanderson T, et al. S100A9 expressed in ER\u2212PgR\u2212 breast cancers induces inflammatory cytokines and is associated with an impaired overall survival. Br J Cancer. 2015;113(8):1234\u201343. https:\/\/doi.org\/10.1038\/bjc.2015.346.","journal-title":"Br J Cancer"},{"issue":"1","key":"575_CR78","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s11658-023-00486-1","volume":"28","author":"X Zhi","year":"2023","unstructured":"Zhi X, Shi S, Li Y, Ma M, Long Y, Li C, et al. S100a9 inhibits Atg9a transcription and participates in suppression of autophagy in cardiomyocytes induced by \u03b21-adrenoceptor autoantibodies. Cell Mol Biol Lett. 2023;28(1):74. https:\/\/doi.org\/10.1186\/s11658-023-00486-1.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"575_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jb\/mvx053","volume":"163","author":"T Okumura","year":"2018","unstructured":"Okumura T, Ikeda K, Ujihira T, Okamoto K, Horie-Inoue K, Takeda S, et al. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation. J Sport Hist Biochem. 2018;163(1):19\u201329. https:\/\/doi.org\/10.1093\/jb\/mvx053.","journal-title":"J Sport Hist Biochem"},{"issue":"7","key":"575_CR80","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.jbc.2022.102083","volume":"298","author":"C Enenkel","year":"2022","unstructured":"Enenkel C, Kang RW, Wilfling F, Ernst OP. Intracellular localization of the proteasome in response to stress conditions. J Biol Chem. 2022;298(7):102083. https:\/\/doi.org\/10.1016\/j.jbc.2022.102083.","journal-title":"J Biol Chem"},{"issue":"1","key":"575_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41420-024-01819-5","volume":"10","author":"P Larsson","year":"2024","unstructured":"Larsson P, Pettersson D, Olsson M, Sarathchandra S, Abramsson A, Zetterberg H, et al. Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. Cell Death Discov. 2024;10(1):57. https:\/\/doi.org\/10.1038\/s41420-024-01819-5.","journal-title":"Cell Death Discov"},{"issue":"13","key":"575_CR82","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/cells11132005","volume":"11","author":"R Sabaratnam","year":"2022","unstructured":"Sabaratnam R, Skov V, Paulsen SK, Juhl S, Kruse R, Hansen T, et al. A signature of exaggerated Adipose Tissue dysfunction in type 2 diabetes is linked to low plasma adiponectin and increased transcriptional Activation of proteasomal degradation in muscle. Cells. 2022;11(13):2005. https:\/\/doi.org\/10.3390\/cells11132005.","journal-title":"Cells"},{"issue":"1","key":"575_CR83","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.1038\/s41598-024-58215-3","volume":"14","author":"M-Y Kim","year":"2024","unstructured":"Kim M-Y, Park E-R, Cho E-H, Park S-H, Han CJ, Kim S-B, et al. Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status. Sci Rep. 2024;14(1):7997. https:\/\/doi.org\/10.1038\/s41598-024-58215-3.","journal-title":"Sci Rep"},{"issue":"22","key":"575_CR84","doi-asserted-by":"publisher","first-page":"24882","DOI":"10.18632\/aging.203722","volume":"13","author":"DTM Xuan","year":"2021","unstructured":"Xuan DTM, Wu C-C, Kao T-J, Ta HDK, Anuraga G, Andriani V, et al. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. Aging (Albany. NY). 2021;13(22):24882\u2013913. https:\/\/doi.org\/10.18632\/aging.203722.","journal-title":"Aging (Albany. NY)"},{"issue":"2","key":"575_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/wrna.1462","volume":"9","author":"DA Lujan","year":"2018","unstructured":"Lujan DA, Ochoa JL, Hartley RS. Cold-inducible RNA binding protein in cancer and inflammation. WIREs RNA. 2018;9(2):9. https:\/\/doi.org\/10.1002\/wrna.1462.","journal-title":"WIREs RNA"},{"key":"575_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biochi.2023.04.003","volume":"217","author":"M Corre","year":"2024","unstructured":"Corre M, Lebreton A. Regulation of cold-inducible RNA-binding protein (CIRBP) in response to cellular stresses. Biochimie. 2024;217:3\u20139. https:\/\/doi.org\/10.1016\/j.biochi.2023.04.003.","journal-title":"Biochimie"},{"issue":"10","key":"575_CR87","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41419-018-1109-5","volume":"9","author":"M Lu","year":"2018","unstructured":"Lu M, Ge Q, Wang G, Luo Y, Wang X, Jiang W, et al. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1\u03b1. Cell Death Dis. 2018;9(10):1046. https:\/\/doi.org\/10.1038\/s41419-018-1109-5.","journal-title":"Cell Death Dis"},{"issue":"14","key":"575_CR88","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1093\/nar\/gkm473","volume":"35","author":"JK Hurt","year":"2007","unstructured":"Hurt JK, Olgen S, Garcia GA. Site-specific modification of shigella flexneri virF mRNA by tRNA-guanine transglycosylase in vitro. Nucleic Acids Res. 2007;35(14):4905\u201313. https:\/\/doi.org\/10.1093\/nar\/gkm473.","journal-title":"Nucleic Acids Res"},{"issue":"Supplement_1","key":"575_CR89","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/db18-1726-P","volume":"67","author":"M Monlun","year":"2018","unstructured":"Monlun M, Rigalleau V, Blanco L, Mohammedi K, Blanco P. Chronic low grade inflammation in type 2 diabetes\u2014Activation of the inflammasomes by circulating metabolites. Diabetes. 2018;67(Supplement_1):67. https:\/\/doi.org\/10.2337\/db18-1726-P.","journal-title":"Diabetes"},{"issue":"1","key":"575_CR90","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13058-025-02098-3","volume":"27","author":"M Dankner","year":"2025","unstructured":"Dankner M, Ouellet V, Lafon J, Ezzeddine R, Annis MG, Abu-Thuraia A, et al. Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes. Breast Cancer Res. 2025;27(1):149. https:\/\/doi.org\/10.1186\/s13058-025-02098-3.","journal-title":"Breast Cancer Res"},{"issue":"7640","key":"575_CR91","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385. https:\/\/doi.org\/10.1038\/nature21363.","journal-title":"Nature"},{"key":"575_CR92","doi-asserted-by":"publisher","first-page":"115864","DOI":"10.1016\/j.bcp.2023.115864","volume":"218","author":"J Yang","year":"2023","unstructured":"Yang J, Lu Y, Su H, Xiao Y, Pan Q, Su F, et al. USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein. Biochemical Pharmacol. 2023;218:115864. https:\/\/doi.org\/10.1016\/j.bcp.2023.115864.","journal-title":"Biochemical Pharmacol"},{"issue":"6","key":"575_CR93","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2013.11.029","volume":"5","author":"Z Lin","year":"2013","unstructured":"Lin Z, Yang H, Tan C, Li J, Liu Z, Quan Q, et al. USP10 antagonizes c-myc transcriptional Activation through SIRT6 stabilization to suppress tumor formation. Cell Rep. 2013;5(6):1639\u201349. https:\/\/doi.org\/10.1016\/j.celrep.2013.11.029.","journal-title":"Cell Rep"},{"issue":"2","key":"575_CR94","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7150\/ijbs.76798","volume":"19","author":"J Shi","year":"2023","unstructured":"Shi J, Zhang Q, Yin X, Ye J, Gao S, Chen C, et al. Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. Int J Biol Sci. 2023;19(2):449\u201364. https:\/\/doi.org\/10.7150\/ijbs.76798.","journal-title":"Int. J. Biol. Sci"},{"key":"575_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcell.2021.757068","volume":"9","author":"L Lu","year":"2021","unstructured":"Lu L, Ma J, Liu Y, Shao Y, Xiong X, Duan W, et al. FSTL1-USP10-Notch1 signaling Axis protects against cardiac dysfunction through inhibition of myocardial Fibrosis in diabetic mice. Front Cell Dev Biol. 2021;9:9. https:\/\/doi.org\/10.3389\/fcell.2021.757068.","journal-title":"Front. Cell Dev. Biol"},{"key":"575_CR96","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fonc.2022.990195","volume":"12","author":"Z Ye","year":"2022","unstructured":"Ye Z, Chen J, Huang P, Xuan Z, Zheng S. Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: assessing its role in tumor prognosis and immune response. Front Oncol. 2022;12:12. https:\/\/doi.org\/10.3389\/fonc.2022.990195.","journal-title":"Front Oncol"},{"issue":"12","key":"575_CR97","doi-asserted-by":"publisher","first-page":"948","DOI":"10.18632\/oncotarget.389","volume":"2","author":"E Madan","year":"2011","unstructured":"Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi AA. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget. 2011;2(12):948\u201357. https:\/\/doi.org\/10.18632\/oncotarget.389.","journal-title":"Oncotarget"},{"issue":"2","key":"575_CR98","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","volume":"6","author":"A Shahbandi","year":"2020","unstructured":"Shahbandi A, Nguyen HD, Jackson JG. TP53 mutations and outcomes in breast cancer: reading beyond the headlines. Trends Cancer. 2020;6(2):98\u2013110. https:\/\/doi.org\/10.1016\/j.trecan.2020.01.007.","journal-title":"Trends Cancer"},{"issue":"4","key":"575_CR99","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang C, Hu W, Feng Z. Tumor suppressor p53 and metabolism. J Mol Cell Biol. 2019;11(4):284\u201392. https:\/\/doi.org\/10.1093\/jmcb\/mjy070.","journal-title":"J Mol Cell Biol"},{"key":"575_CR100","doi-asserted-by":"publisher","unstructured":"Kung C-P, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol. 2016;231(2):R61\u201375. https:\/\/doi.org\/10.1530\/JOE-16-0324.","DOI":"10.1530\/JOE-16-0324"},{"key":"575_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fendo.2018.00457","volume":"9","author":"K Zwezdaryk","year":"2018","unstructured":"Zwezdaryk K, Sullivan D, Saifudeen Z. The p53\/Adipose-Tissue\/Cancer nexus. Front. Endocrinol. (Lausanne). 2018;9:9. https:\/\/doi.org\/10.3389\/fendo.2018.00457.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"575_CR102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-08-0356","volume":"159","author":"C Holzapfel","year":"2008","unstructured":"Holzapfel C, Baumert J, Grallert H, M\u00fcller AM, Thorand B, Khuseyinova N, et al. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA\/KORA Augsburg case\u2013cohort study, 1984\u20132002. Eur J Endocrinol. 2008;159(4):407\u201316. https:\/\/doi.org\/10.1530\/EJE-08-0356.","journal-title":"Eur J Endocrinol"},{"key":"575_CR103","doi-asserted-by":"crossref","unstructured":"Qiu Y, Chen A, Yu R, et al. Insulin resistance increases TNBC aggressiveness and brain metastasis via adipocyte-derived Exosomes. 2024.","DOI":"10.1101\/2024.05.01.592097"},{"issue":"1","key":"575_CR104","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1038\/srep04650","volume":"4","author":"Y-M Fan","year":"2014","unstructured":"Fan Y-M, Hernesniemi J, Oksala N, Levula M, Raitoharju E, Collings A, et al. Upstream transcription factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque. Sci Rep. 2014;4(1):4650. https:\/\/doi.org\/10.1038\/srep04650.","journal-title":"Sci Rep"},{"issue":"4","key":"575_CR105","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng1320","volume":"36","author":"P Pajukanta","year":"2004","unstructured":"Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36(4):371\u201376. https:\/\/doi.org\/10.1038\/ng1320.","journal-title":"Nat Genet"},{"key":"575_CR106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fonc.2025.1579423","volume":"15","author":"X Cai","year":"2025","unstructured":"Cai X, Zhang Z, Yang X, Shen W-R, Yuan L-W, Ding X, et al. Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options. Front Oncol. 2025;15:15. https:\/\/doi.org\/10.3389\/fonc.2025.1579423.","journal-title":"Front Oncol"},{"key":"575_CR107","doi-asserted-by":"publisher","unstructured":"Zou K, Zeng Z. Role of early growth response 1 in inflammation-associated lung diseases. Am J Physiol-Lung Cellular Mol Physiol. 2023;325(2):L143\u201354. https:\/\/doi.org\/10.1152\/ajplung.00413.2022.","DOI":"10.1152\/ajplung.00413.2022"},{"key":"575_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2021.642547","volume":"11","author":"B Wang","year":"2021","unstructured":"Wang B, Guo H, Yu H, Chen Y, Xu H, Zhao G. The role of the transcription factor EGR1 in cancer. Front Oncol. 2021;11:11. https:\/\/doi.org\/10.3389\/fonc.2021.642547.","journal-title":"Front Oncol"},{"issue":"6","key":"575_CR109","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1159\/000430177","volume":"36","author":"D Wang","year":"2015","unstructured":"Wang D, Guan M-P, Zheng Z-J, Li W-Q, Lyv F-P, Pang R-Y, et al. Transcription factor Egr1 is involved in high glucose-induced proliferation and Fibrosis in rat glomerular mesangial cells. Cell Physiol Biochem. 2015;36(6):2093\u2013107. https:\/\/doi.org\/10.1159\/000430177.","journal-title":"Cell Physiol Biochem"},{"key":"575_CR110","doi-asserted-by":"publisher","unstructured":"Fan C, Liu N. Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple\u2011negative breast cancer: an in silico study. Oncol Rep. 2019. https:\/\/doi.org\/10.3892\/or.2019.7094.","DOI":"10.3892\/or.2019.7094"},{"issue":"21","key":"575_CR111","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-10-1938","volume":"70","author":"L Hong","year":"2010","unstructured":"Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, et al. The miR-17-92 Cluster of MicroRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010;70(21):8547\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1938.","journal-title":"Cancer Res"},{"issue":"7","key":"575_CR112","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.celrep.2016.07.036","volume":"16","author":"S Izreig","year":"2016","unstructured":"Izreig S, Samborska B, Johnson RM, Sergushichev A, Ma E, Lussier C, et al. The miR-17\u223c92 microRNA Cluster is a global regulator of tumor metabolism. Cell Rep. 2016;16(7):1915\u201328. https:\/\/doi.org\/10.1016\/j.celrep.2016.07.036.","journal-title":"Cell Rep"},{"issue":"1","key":"575_CR113","doi-asserted-by":"publisher","first-page":"25022","DOI":"10.1038\/s41598-024-75557-0","volume":"14","author":"ES Tylden","year":"2024","unstructured":"Tylden ES, Delgado AB, Lukic M, Moi L, Busund L-TR, Pedersen MI, et al. Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies. Sci Rep. 2024;14(1):25022. https:\/\/doi.org\/10.1038\/s41598-024-75557-0.","journal-title":"Sci Rep"},{"issue":"8_Supplement_1","key":"575_CR114","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1158\/1538-7445.AM2025-2360","volume":"85","author":"LFT Cando","year":"2025","unstructured":"Cando LFT, Ju Z, Dalmacio LMM, Gunaratne PH, Wang J, Bhardwaj A, et al. Abstract 2360: targeting of microRNA let-7b-5p-mediated aberrant AR signaling inhibits the growth and proliferation of preneoplastic and preinvasive stages of triple-negative breast cancer. Cancer Res. 2025;85(8_Supplement_1):2360\u20132360. https:\/\/doi.org\/10.1158\/1538-7445.AM2025-2360.","journal-title":"Cancer Res"},{"issue":"1","key":"575_CR115","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41420-023-01412-2","volume":"9","author":"L Li","year":"2023","unstructured":"Li L, Zhang X, Lin Y, Ren X, Xie T, Lin J, et al. Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis. Cell Death Discov. 2023;9(1):114. https:\/\/doi.org\/10.1038\/s41420-023-01412-2.","journal-title":"Cell Death Discov"},{"issue":"8","key":"575_CR116","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40265-020-01317-9","volume":"80","author":"A Markham","year":"2020","unstructured":"Markham A. Tepotinib: first approval. Drugs. 2020;80(8):829\u201333. https:\/\/doi.org\/10.1007\/s40265-020-01317-9.","journal-title":"Drugs"},{"issue":"2","key":"575_CR117","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1872-034X.2007.00297.x","volume":"38","author":"T I","year":"2008","unstructured":"I T, M Y. Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatol Res. 2008;38(2):123\u201331. https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00297.x.","journal-title":"Hepatol Res"},{"issue":"7","key":"575_CR118","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arabjc.2024.105802","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu L, Tao Q, Zhou B, Zhu Z. The interaction mechanism of tepotinib and \u03b1-glucosidase: a prelude to control type 2 diabetes mellitus. Arabian J Chem. 2024;17(7):17. https:\/\/doi.org\/10.1016\/j.arabjc.2024.105802.","journal-title":"Arabian J Chem"},{"issue":"6","key":"575_CR119","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ol.2022.13290","volume":"23","author":"G Jing","year":"2022","unstructured":"Jing G, Yu F, Xue H. Tepotinib suppresses proliferation, invasion, migration, and promotes apoptosis of melanoma cells via inhibiting MET and PI3K\/AKT signaling pathways. Oncol Lett. 2022;23(6):23. https:\/\/doi.org\/10.3892\/ol.2022.13290.","journal-title":"Oncol Lett"},{"issue":"5","key":"575_CR120","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biomedicines12051087","volume":"12","author":"IE Pralea","year":"2024","unstructured":"Pralea IE, Moldovan RC, \u021aigu AB, Moldovan C-S, Fischer-Fodor E, Iuga C-A. Cellular responses induced by NCT-503 treatment on triple-negative breast cancer cell lines: a proteomics approach. Biomedicines. 2024;12(5):12. https:\/\/doi.org\/10.3390\/biomedicines12051087.","journal-title":"Biomedicines"},{"key":"575_CR121","doi-asserted-by":"publisher","unstructured":"Laki\u0107 B, \u0160krbi\u0107 R, Uletilovi\u0107 S, Mandi\u0107-Kova\u010devi\u0107 N, Grabe\u017e M, \u0160ari\u0107 MP, et al. Beneficial effects of Ursodeoxycholic acid on metabolic parameters and oxidative stress in patients with type 2 diabetes mellitus: a randomized Double-Blind, placebo-controlled clinical study. J Diabetes Res. 2024;2024(1). https:\/\/doi.org\/10.1155\/2024\/4187796.","DOI":"10.1155\/2024\/4187796"},{"issue":"1","key":"575_CR122","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmjdrc-2017-000469","volume":"6","author":"KR S","year":"2018","unstructured":"S KR, O T, K K-I, Takeshita Y, Misu H, Kaneko S, et al. Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study. BMJ Open Diab Res Care. 2018;6(1):6. https:\/\/doi.org\/10.1136\/bmjdrc-2017-000469.","journal-title":"BMJ Open Diab Res Care"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-026-00575-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-026-00575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-026-00575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:04:27Z","timestamp":1788134667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13040-026-00575-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1186\/s13040-026-00575-9","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable, since the datasets analyzed in this study were downloaded from online sources that are freely available without any restriction.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"70"}}